AIVITA Biomedical Announces Treatment of First Two Patients in Phase 2 Glioblastoma Trial
AIVITA Biomedical Announces Treatment of First Two Patients in Phase 2 Glioblastoma Trial IRVINE, Calif., Nov. 16, 2018 /PRNewswire/ — AIVITA Biomedical announced today that it has dosed the first two patients in its Phase 2 clinical trial in patients with newly diagnosed glioblastoma. The trial is designed to investigate AIVITA Biomedical’s next-generation patient-specific cancer […]